Immunogen (IMGN) Director Buys 20K Shares
Get Alerts IMGN Hot Sheet
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) Director, Mark Alan Goldberg, bought 20,000 shares on 12/15 at $1.80
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore says this stock could gain 45% if AI trade is back "in full force"
- BNP Paribas says buy this stock, sees nearly 100% upsideh
- U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share